NCT07180472View on ClinicalTrials.gov

Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

632

Participants

Timeline

Start Date

September 20, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

December 1, 2027

Conditions
Cerebral Small Vessel Disease
Interventions
DRUG

Cilostazol

Oral administration of cilostazol

DRUG

Aspirin

Oral administration of Asprin

DRUG

Clopidogrel

Oral administration of Clopidogrel

All Listed Sponsors
lead

First Affiliated Hospital of Chengdu Medical College

OTHER